Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,426 | -15,754 | -19,375 | -11,168 | -8,735 |
| Depreciation Amortization | 447 | 1,279 | 663 | 387 | 301 |
| Accounts payable and accrued liabilities | 741 | 1,002 | -48 | 229 | 1,042 |
| Other Working Capital | -1,555 | 993 | -686 | 2,337 | 2,325 |
| Other Operating Activity | 3,078 | 831 | 6,061 | 693 | 838 |
| Operating Cash Flow | $-19,715 | $-11,649 | $-13,385 | $-7,522 | $-4,229 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -918 | -31 | -91 | -106 | -500 |
| Net Acquisitions | N/A | N/A | 934 | N/A | N/A |
| Purchase Of Investment | -11,245 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 815 |
| Other Investing Activity | -252 | 0 | 0 | -75 | 0 |
| Investing Cash Flow | $-12,415 | $-31 | $843 | $-181 | $315 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -516 | N/A | 1,982 | N/A | N/A |
| Debt Repayment | -1,121 | -1,181 | -398 | -114 | N/A |
| Common Stock Issued | 46,505 | 13,650 | 8,384 | 10,768 | 11,653 |
| Other Financing Activity | 3,000 | -355 | 0 | -773 | 0 |
| Financing Cash Flow | $47,868 | $12,114 | $9,968 | $9,881 | $11,653 |
| Beginning Cash Position | 8,034 | 7,600 | 10,174 | 7,996 | 257 |
| End Cash Position | 23,772 | 8,034 | 7,600 | 10,174 | 7,996 |
| Net Cash Flow | $15,738 | $434 | $-2,574 | $2,178 | $7,739 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,715 | -11,649 | -13,385 | -7,522 | -4,229 |
| Capital Expenditure | -918 | -31 | -91 | -106 | -500 |
| Free Cash Flow | -20,633 | -11,680 | -13,476 | -7,628 | -4,729 |